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ABSTRACT
DNA methylation is a crucial epigenetic mark associated to gene silencing, and its targeted removal is a
major goal of epigenetic editing. In animal cells, DNA demethylation involves iterative 5mC oxidation by
TET enzymes followed by replication-dependent dilution and/or replication-independent DNA repair of its
oxidized derivatives. In contrast, plants use specific DNA glycosylases that directly excise 5mC and initiate
its substitution for unmethylated C in a base excision repair process. In this work, we have fused the
catalytic domain of Arabidopsis ROS1 5mC DNA glycosylase (ROS1_CD) to the DNA binding domain of
yeast GAL4 (GBD). We show that the resultant GBD-ROS1_CD fusion protein binds specifically a GBD-
targeted DNA sequence in vitro. We also found that transient in vivo expression of GBD-ROS1_CD in
human cells specifically reactivates transcription of a methylation-silenced reporter gene, and that such
reactivation requires both ROS1_CD catalytic activity and GBD binding capacity. Finally, we show that
reactivation induced by GBD-ROS1_CD is accompanied by decreased methylation levels at several CpG
sites of the targeted promoter. All together, these results show that plant 5mC DNA glycosylases can be
used for targeted active DNA demethylation in human cells.
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DNA methylation at carbon 5 of cytosine (5-methylcytosine,
5mC) is a stable but reversible epigenetic mark associated to gene
silencing, and plays essential roles in development and genome
defense against transposons.1 Modification of DNA methylation
patterns in both normal and pathological conditions results from
both methylation and demethylation processes, but in animal
cells the latter are not yet well understood.2 Demethylation
involves either dilution of 5mC by DNA replication in the
absence of methylation, designated passive DNA demethylation,
or enzymatic processes for replication-independent removal of
5mC, termed active DNA demethylation.3
Accumulating evidence suggests that DNA demethylation in
mammalian cells involves iterative oxidation of 5mC by TET
dioxygenases, followed by either passive replication-dependent
dilution or active removal of oxidized 5mC derivatives through
DNA repair (reviewed in4,5). However, the emerging picture is
still unclear because the magnitude of passive dilution com-
pared to active DNA repair is unknown2 and, moreover, oxi-
dized forms of 5mC may behave as independent epigenetic
marks on their own.6
Unlike animals, plants are able to remove 5mC without prior
modification. Convincing biochemical and genetic evidence indi-
cates that proteins belonging to a plant-specific family of DNA
glycosylases directly excise 5mC from DNA and initiate active
DNA demethylation through a base excision repair (BER) path-
way.7-9 Arabidopsis thaliana REPRESSOR OF SILENCING 1
(ROS1) is a representative member of this 5mC DNA glycosylase
family, whose members are uniquely characterized by a discon-
tinuous DNA glycosylase domain,10 a conserved C-terminal
domain that is essential for the catalytic activity,11,12 and a basic
amino-terminal domain that mediates nonspecific binding to
DNA but it is not required for catalysis.13
The understanding of active DNA demethylation mecha-
nisms may have broad implications for epigenetic editing, a
new discipline aimed to develop molecular tools to modulate
gene expression. One of its most promising approaches is to
overwrite epigenetic marks at specific genome regions by tar-
geting epigenetic effector domains (EDs) fused to a DNA bind-
ing domain (DBD) that specifically recognizes a particular
DNA sequence.14 These chimeric proteins can be very useful in
basic research15 and might also have important applications in
the study of diseases that show epigenetic alterations, such as
cancer.16,17 Recent studies have shown targeted DNA demeth-
ylation and gene reactivation in mammalian cells by fusing dif-
ferent enzymes involved in DNA demethylation to diverse
DBDs.18-22 However, no efforts have been reported so far to
express or target plant 5mC DNA glycosylases, which directly
excise 5mC from DNA.
In this work, we have explored the possibility of directing
ROS1 DNA glycosylase activity to a specific target sequence in
human cells. We hypothesized that it would be possible to
replace Arabidopsis thaliana ROS1 N-terminal domain by a
specific DBD without changing its catalytic efficiency. As a
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proof of concept, we have fused the catalytic domain of ROS1
(ROS1_CD) with the GAL4 DNA binding domain (GBD), a
well-characterized DBD that specifically binds the GAL
upstream activating sequence (UAS).23 GBD has been previ-
ously used for targeting the catalytic domain of mouse DNA
methyltransferases DNMT3a and DNMT3b in human cells.24
The targeted binding capacity of GBD-ROS1_CD was first ana-
lyzed in vitro and then the fusion protein was transiently
expressed in a human cell line. We have found that transient
expression of GBD-ROS1_CD in human cells promotes tar-
geted DNA demethylation and reactivation of a methylation-
silenced reporter gene.
Results
GBD-ROS1_CD binds preferentially a DNA containing a
GAL4-target sequence
To target DNA demethylation to a specific sequence, we fused the
GAL4 DNA binding domain (GBD) to a truncated ROS1 version
lacking its lysine-rich N-terminal domain [ROS1_CD, previously
designated as ROS1ND29413]. We first examined the in vitro bind-
ing properties of the recombinant fusion protein, which was over-
expressed inE. coli and purified as aN-terminalHis-tagged protein.
We analyzed the DNA binding specificity of GBD-
ROS1_CD by electrophoretic mobility shift assay (EMSA)
(Fig. 1). Increasing concentrations of GBD-ROS1_CD were
incubated with either a GBD-targeted substrate or a non-tar-
geted substrate (Fig. 1B). Both substrates are 60 bp-long, but
the targeted DNA (UAS) contains an upstream activating
sequence (50-CGGAGGACAGTACTCCG-30) that is absent in
the non-targeted DNA (no-UAS) (Table S2). At protein con-
centrations lower than 60 nM, a significantly higher percentage
of DNA-protein complexes were detected with the targeted
DNA in comparison with the non-targeted probe (Fig. 1B).
The binding isotherm for the targeted DNA is hyperbolic
(Fig. 1C), indicative of a true equilibrium process. Using a
Scatchard plot, an apparent dissociation constant (Kdapp) of
12.8 nM was estimated. A reliable estimate of Kdapp could not
be obtained for the no-UAS substrate (Fig. S1). These results
indicate that GBD-ROS1_CD fusion protein binds preferen-
tially DNA molecules containing sequences targeted by the
GAL4 DNA binding domain.
GBD-ROS1_CD and its mutant variants are efficiently
expressed after transient transfection in HEK293 cells
We next explored the possibility to direct the DNA demethylation
activity of GBD-ROS1_CD to UAS sequences in human cells by
using a luciferase reporter system. The plasmid constructed for
expression of GBD-ROS1_CD in human cells encodes a 1304 aa-
protein with a Flag-tag at the N-terminus, and a c-myc tag and a
nuclear localization signal (NLS) between GBD and ROS1_CD
(Fig. 2A).We additionally generated two control constructs encod-
ing mutant versions of the fusion protein. GBD-ROS1_CDmut
contains a mutation in the DNA glycosylase domain of ROS1 that
changes to alanine an invariant aspartic acid residue (D971 in full-
length ROS1) and completely abolishes the catalytic activity of the
protein.7 The GBDmut-ROS1_CD version contains a double
mutation in the GBD domain (L32P and C38G in full-length
GAL4) that abrogates its DNA binding capacity.25
We co-transfected each expression construct in HEK293 cells
with a targeted reporter plasmid expressing the firefly luciferase
gene under the control of a TK promoter and five copies of the
GBD-targeted sequence (5xUAS) (Fig. 2B). A non-targeted
reporter plasmid containing a TK promoter with no UAS
sequence was used as control (Fig. 2B). The firefly reporter vectors
were previously methylated in vitro with M.SssI. A second
reporter plasmid expressing Renilla luciferase gene (RLL) under
the control of a CMV promoter (pRL-CMV, Promega) was used
for normalization of transfection yield and cell number in all
co-transfection experiments.
Figure 1. Analysis of the DNA binding capacity of GBD-ROS1_CD in vitro. (A) Sche-
matic diagram of the His-tagged GBD-ROS1_CD recombinant fusion protein. ROS1_CD
comprises residues 295–1393 of ROS1, and contains a non-contiguous DNA glycosy-
lase domain distributed over two segments (blue and red) separated by a non-struc-
tured linker region (striped), and a C-terminal domain (yellow). (B) Increasing
concentrations of purified GBD-ROS1_CD were incubated at 25C for 30 min with
10 nM of fluorescein-labeled DNA duplex containing (UAS) or not (no-UAS) the
sequence targeted by GBD. After non-denaturing gel electrophoresis, gels were
scanned to detect fluorescein-labeled DNA. Protein–DNA complexes were identified
by their retarded mobility compared with that of free DNA. A representative gel for
each substrate is shown. (C) Percentage of protein–DNA complexes versus protein
concentration. All bands with slower mobility were used in quantitation of bound pro-
tein. Values are mean§ SE (error bars) from three independent experiments.
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The co-transfection efficiency with different combinations
of constructs ranged between 70–75%, as measured by flow
cytometry 48 h after co-transfection with a GFP-expressing
reporter plasmid (Fig. S2). By Western-blot analysis after co-
transfection with either the targeted or the non-targeted
reporter vector, we confirmed the transient expression of all
three GBD-ROS1_CD versions in HEK293 cells (Fig. 2C).
Transient expression of GBD-ROS1 in HEK293 cells
reactivates a methylation-silenced reporter gene
As expected, the luciferase activity of both targeted (5xUAS-TK-
Luc) and non-targeted (TK-Luc) reporter plasmids in HEK293
cells was reduced by about 98% after in vitro methylation by M.
SssI (Fig. 3). These results confirm that the TK promoter is highly
sensitive to DNAmethylation, as previously reported.24 We deter-
mined the effect exerted by the transient expression of different
GBD-ROS1_CD versions on this silenced luciferase activity
(Fig. 3). We found that co-transfection with GBD-ROS1_CD sig-
nificantly increased the luciferase activity of the targeted (5xUAS-
TK-Luc) reporter gene by 3.4-fold (P < 0.001) (Fig. 3A) com-
pared to that observed with the empty expression vector. In con-
trast, no significant increase was detected in the untargeted (TK-
Luc) gene (Fig. 3B). When either the GBD-ROS1_CDmut or the
GBDmut-ROS1_CD mutant variants were transiently expressed,
no significant increase in luciferase activity was detected, either
with the targeted or the non-targeted reporter gene (Fig. 3). All
together, these results suggest that both ROS1_CD catalytic activ-
ity and specific DNA binding by GBD are required for targeted
gene reactivation by the fusion protein GBD-ROS1_CD in vivo.
Targeted transcriptional activation of the silenced reporter
gene by GBD-ROS1_CD
We next examined whether changes in luciferase activity corre-
late with mRNA levels of the luciferase reporter gene. We iso-
lated total RNA 48 h after co-transfection of either the targeted
or the non-targeted reporter plasmid with constructs expressing
different GBD-ROS1_CD versions, and levels of the firefly lucif-
erase transcript were analyzed by quantitative real-time PCR
(qRT-PCR). As expected, in vitro methylation of the reporter
plasmids strongly decreased transcript levels of both the targeted
(5xUAS-TK-Luc) and the non-targeted (TK-Luc) genes (Fig. 4).
We found that the transient expression of GBD-ROS1_CD sig-
nificantly increased mRNA levels of the silenced targeted (5xUAS-
TK-Luc) gene by 2.2-fold (P < 0.05), compared to those observed
Figure 2. Transient expression of GBD-ROS1_CD and its mutant variants in HEK293 cells. (A-B) Schematic diagrams of effector and reporter constructs used for co-trans-
fection of HEK293 cells. Control effector constructs contain either a mutation in the ROS1 catalytic domain (GBD-ROS1_CDmut) or two mutations in GBD that abolish bind-
ing to target UAS sequences (GBDmut-ROS1_CD). Reporter constructs contain the TK promoter fused to the firefly luciferase gene. The targeted version (5xUAS-TK-Luc)
includes five copies of GBD binding sites upstream the TK promoter that are absent in the non-targeted control (TK-Luc). (C) Transient expression of GBD-ROS1_CD fusion
proteins in HEK293 cells. Western-blot analysis with an anti-Flag antibody was performed in cell extracts (80 mg) prepared 48 h after co-transfection of different effector
constructs with either the targeted (upper panels) or the non-targeted (lower panels) methylated reporter plasmid. Actin was used as an input control.
Figure 3. Targeted reactivation of luciferase activity by transient expression of GBD-ROS1_CD. Cells were co-transfected with the indicated effector construct and either
the targeted (A) or non-targeted (B) version of the in vitro-methylated reporter plasmid. Luciferase activity, determined 48 h after co-transfection, is shown relative to
that detected after co-transfection with empty vector and unmethylated reporter. Values are means § SE (error bars) from three independent transfection experiments.
Asterisks indicate statistically significant differences (P < 0.001; Student’s unpaired t-test).
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with the empty expression vector (Fig. 4A). In contrast, we did not
observe any noticeable effect of GBD-ROS1_CD on the non-tar-
geted (TK-Luc) gene mRNA levels (Fig. 4B). As previously
observed with luciferase activity, neither the GBD-ROS1_CDmut
nor the GBDmut-ROS1_CDmutant variant significantly increased
luciferase transcript levels. All together, these results indicate that
transient expression of GBD-ROS1_CD in human cells specifically
activates transcription of a methylated GBD-targeted gene, and
that such activation requires both the catalytic activity of
ROS1_CD and the DNA binding capacity of GBD.
Transient expression of GBD-ROS1_CD induces partial
demethylation of the 5xUAS region
The results reported above strongly suggest that GBD-
ROS1_CD can induce the transcriptional reactivation of a
methylation-silenced gene. To examine whether such reactiva-
tion involves DNA methylation changes, we performed bisulfite
DNA pyrosequencing of the 5xUAS region after
transient expression of either GBD-ROS1_CD or its mutant
variants. A total of 35 CpG sites distributed over a 302-bp
region were analyzed (Fig. 5). We found a modest, but statisti-
cally significant, decrease of methylation levels in a region
covering about 200 bp, when compared to those detected in
cells transfected with the empty vector. Importantly, DNA
demethylation declined as distance from the 5xUAS region
increased. This result suggests that the DNA demethylation
range is determined by the distance to the site of GBD-target-
ing. Very similar results were observed when comparing cells
expressing wild type GBD-ROS1_CD with control cells
expressing either the GBD-ROS1_CDmut or the GBDmut-
ROS1 mutant variant. These results strongly suggest that the
Figure 4. Targeted transcriptional activation of luciferase reporter gene by transient expression of GBD-ROS1. Cells were co-transfected with the indicated effector con-
struct and either the targeted (A) or non-targeted (B) version of the in vitro methylated reporter plasmid. Levels of firefly luciferase transcript, assessed 48 h after transfec-
tion by qRT-PCR and normalized to GAPDH, are shown relative to those detected after co-transfection with empty vector and unmethylated reporter. Values are means §
SE (error bars) from three independent transfection experiments. Asterisks indicate statistically significant differences (P < 0.05; Student’s unpaired t-test).
Figure 5. DNA methylation analysis of the targeted 5xUAS-TK region after transient expression of GBD-ROS1_CD. (A) Schematic diagram of the analyzed region. CpG sites
are shown in red. (B) Quantitative methylation analysis. Cells were co-transfected with the indicated effector construct and the targeted methylated reporter plasmid.
Plasmid DNA was re-isolated 48 h after co-transfection, bisulfite-treated, PCR-amplified, and pyrosequenced. The graph shows the percentage of methylation at different
positions. Values are means § SE (error bars) from three independent transfection experiments. Asterisks indicate statistically significant differences between GBD-ROS1
and the empty vector (: P < 0.05; : P < 0.01; : P < 0.001; Student’s unpaired t-test).
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5mC DNA glycosylase activity of ROS1 can be targeted to
specific sequences to induce active DNA demethylation.
Discussion
The GBD-ROS1_CD fusion protein comprises a version of
ROS1 lacking the N-terminal 294 amino acids, a region that
binds non-specifically both unmethylated and methylated
DNA, but it is not essential for enzymatic activity.13 We
hypothesized that replacing the N-terminal domain with a
well-characterized DBD would render a protein able to target
specific DNA sequences. By using in vitro DNA binding assays,
we have found that GBD-ROS1_CD fusion protein binds pref-
erentially DNA molecules containing the GAL4 DNA binding
domain target sequence. We also detected some non-specific
binding to DNA lacking the target sequence. Although it can-
not be ruled out that the ROS1_CD portion of the protein may
contribute to such non-specific binding, there might be alterna-
tive factors involved. GBD contains a Cys6-zinc cluster motif
26
and, as other zinc-coordinating DNA-binding proteins is
expected to bind non-specifically to DNA while searching for
its target site among an enormous amount of non-specific
sites.27 Furthermore, it has been reported that GBD is able to
recognizes a variety of UAS sequences that adjust to the general
formula (A/C)GGN10–12CCG and that DNA binding specificity
is more stringent in vivo than in vitro.28
We have shown that transient expression of GBD-
ROS1_CD in HEK293 cells significantly increases transcription
of a methylated 5xUAS-TK-Luc reporter gene. Importantly,
reactivation is not observed if the GBD region contains two
mutations abrogating its DNA binding capacity. This result
suggests that, even if the non-GBD portion might retain some
non-specific DNA binding capacity in vivo, it does not lead to
efficient reactivation. Furthermore, the fact that reactivation
was not observed when the reporter plasmid did not include
the targeted UAS sequence strongly suggests that GBD-
ROS1_CD has a low off-target rate in vivo.
Another important observation is that reactivation depends
upon the 5mC DNA glycosylase activity of ROS1_CD. This
result rules out any indirect effect arising from targeting a volu-
minous protein to the methylated promoter, for example by
preventing recruitment of methyl-CpG binding proteins
(MBP) and other repressor factors. In fact, we have found that
HEK293 cells that transiently express GBD-ROS1_CD display
reduced methylation levels at several CpG sites in the 5xUAS
region, but that such decrease is not observed in cells express-
ing a catalytically inactive mutant version or a binding deficient
mutant variant, this strongly suggests that the significant
increase in luciferase activity induced by GBD-ROS1_CD was
directly caused by a targeted DNA demethylation activity.
By using bisulfite-based methods, previous studies have
reported targeted DNA demethylation in mammalian cells
with TET proteins fused to ZFPs, TALEs, or dCas9 pro-
tein.18,19,21,22 TET enzymes mediate DNA demethylation indi-
rectly through oxidation of 5mC to 5hmC, and further
oxidation of 5hmC to 5fC and 5caC.29,30 However, bisulfite
sequencing does not distinguish between unmethylated C and
either 5fC or 5caC, since these two derivatives are not resistant
to deamination.31 Therefore, distinguishing bona fide DNA
demethylation from 5mC oxidation in the context of TET-tar-
geting is problematic. A further complicating factor arises
when distinguishing passive from active DNA demethylation.
So far, studies reporting TET-mediated demethylation used
potentially replicating DNA targets, which makes difficult to
rule out passive dilution. In the present study, however, passive
DNA demethylation is excluded because the reporter plasmid
lacks an origin of replication.
Active DNA demethylation induced by the transient expres-
sion of GBD-ROS1 leads to a modest decrease in DNA methyl-
ation levels. The possibility that at least part of the 5mC loss is
being counteracted by de novo and maintenance DNA methyla-
tion cannot be ruled out. In any case, such a limited demethyla-
tion exerts a significant effect on transcription activity. Several
studies have previously suggested that partial changes in meth-
ylation might be sufficient to induce gene expression reactiva-
tion, emphasizing the potential of DNA demethylation for
modulation of gene expression. For example, TDG fused to the
Nuclear Factor kB (NF-kB) DNA binding domain caused a 5–
10% reduction in methylation levels at the target CpG sites,
leading to a 3-fold increase induction of gene expression in 3T3
cells.20 Furthermore, TET2 fused to a ZFP (CD54) that binds
ICAM-1 promoter, partially demethylates the CpG sites in the
surrounding region of the ZF binding site in A2780 cells, lead-
ing to a 2-fold increase in gene expression.18 Conversely, there
is also evidence showing that increasing methylation of a single
CpG site can be sufficient to repress gene expression.32
In conclusion, this work demonstrates that targeted expres-
sion of ROS1 catalytic domain in human cells reactivates a
methylation-silenced gene in a replication-independent man-
ner. Further work with different types of engineered DBDs and
endogenous targets will be required to establish the utility of
plant 5mC DNA glycosylases in epigenetic editing.
Materials and methods
GBD-ROS1_CD expression and purification in E. coli
The pET28c-ROS1ND294 plasmid13 was used as a backbone to
obtain a plasmid expressing GBD-ROS1_CD protein with an
N-terminal His6-tag. A fragment containing the GAL4 DNA
Binding Domain (GBD, 1–147 amino acids), a c-myc tag and a
nuclear localization signal (NLS, PKKKKRK), was amplified by
PCR from pcDNA3.1-GBD,24 using primers with NheI and
EcoRI restriction sites (Table S1). The PCR product was
digested, subcloned between the His6-tag and ROS1_CD into
pET28c-ROS1ND294, and verified by DNA sequencing. The
recombinant His-GBD-ROS1_CD protein was overexpressed
and purified as previously described.13
Plasmid construction for GBD-ROS1_CD expression in
human cells
A DNA fragment containing the ROS1_CD coding sequence
was released from pET28c-ROS1ND294 by EcoRI-HindIII
digestion and subcloned into pCMVTag2B vector (Strata-
gene) to obtain pCMVTag2B-ROS1_CD. Then, a fragment
containing GAL4 DNA Binding Domain (GBD, 1–147
amino acids), a c-myc tag, and a nuclear localization signal
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(NLS, PKKKKRK), was amplified from pcDNA3.1-GBD
using primers with a PstI restriction site (Table S1). The
amplification product was digested with PstI and inserted
into pCMVTag2B-ROS1_CD, downstream the Flag-tag
and upstream ROS1_CD, to obtain pCMVTag2B-GBD-
ROS1_CD. Constructs expressing the catalytically inactive
and the binding-deficient GBD-ROS1_CD mutant versions
(GBD-ROS1_CDmut and GBDmut-ROS1_CD, respectively)
were obtained by site-directed mutagenesis of pCMVTag2B-
GBD-ROS1_CD using the Quick-Change II XL kit (Strata-
gene) and specific oligonucleotides (Table S1). Mutational
changes were confirmed by DNA sequencing.
Luciferase reporter plasmids
The reporter plasmid 5xUAS-TK-Luc24 is derived from the
pGL3-basic vector (Promega) and contains five repeats of the
upstream activating sequence (5xUAS) and the minimal
human herpesvirus 1 thymidylate kinase (TK) promoter (156
bp) upstream the firefly luciferase reporter gene. The non-tar-
geted (TK-Luc) reporter plasmid was obtained by replacing the
5xUAS-TK sequence with a TK-PCR fragment flanked by XhoI
and HindIII sites (Table S1). A reporter plasmid containing the
Renilla luciferase reporter gene under the control of the cyto-
megalovirus (CMV) promoter (pRL-CMV; Promega) was used
for normalization of transfection yield and cell number in all
co-transfection experiments involving luciferase expression
analysis.
In vitro methylation of firefly-luciferase reporter plasmid
DNA (50 mg) was performed by incubation with M.SssI CpG
methyltransferase (160 U, New England Biolabs) in a reaction
mixture containing 50 mM NaCl, 10 mM Tris–HCl pH 7.9,
10 mM EDTA and 0.8 mM S-adenosylmethionine (SAM), at
37C overnight. After incubation, plasmid DNA was purified
by ethanol precipitation. Methylation was verified by confirm-
ing full resistance to HpaII digestion.
Electrophoretic mobility shift assay (EMSA)
Oligonucleotides used to generate DNA duplexes for elec-
trophoretic mobility shift assays (EMSA) (Table S2) were
synthesized by Operon or Integrated DNA Technologies
(IDT) and purified by polyacrylamide gel electrophoresis
(PAGE) or dual HPLC before use. Double-stranded DNA
substrates were prepared by mixing a 5 mM solution of a
50-fluorescein-labeled oligonucleotide (upper-strand) with a
10 mM solution of an unlabeled oligomer (lower-strand),
heating to 95C for 5 min and slowly cooling to room
temperature.
For EMSA reactions, increasing amounts of GBD-ROS1_CD
were incubated with fluorescein-labeled duplex DNA (10 nM).
DNA binding reactions were carried out at 25C for 30 min, in
10 mM Tris–HCl, pH 8.0, 1 mM DTT, 10 mg/ml BSA, 20 mM
ZnSO4, in a final volume of 10 ml. Complexes were electrophor-
esed through 0.2% agarose gels in 1X TAE (40 mM Tris–HCl,
pH 8.0, 20 mM acetic acid, 1 mM EDTA). Electrophoresis was
carried out in 1X TAE for 40 min at 80 V at room temperature.
Fluorescein-labeled DNA was visualized in a FLA-5100 imager
and analyzed using Multigauge software (Fujifilm).
The dissociation constant was calculated as described in.33
Data were analyzed using linear regression with Sigmaplot soft-
ware according to Scatchard equation:
r 6 ½PD ¡ 1 6 Kdapp
   r C n 6 Kdapp (1)
GBDROS1-DNA½  D ¡ .1=Kdapp/  GBDROS1-DNA½  C n=Kdapp
½total DNA  ½GBDROS1 ½total DNA
where r is the ratio of bound DNA to total DNA ([GBDROS1-
DNA] / [total DNA]), [P] is GBD-ROS1_CD concentration
([GBDROS1]), Kdapp is the apparent dissociation constant and
n is the number of binding sites for GBD-ROS1_CD protein.
The Kdapp value corresponds to the negative reciprocal of the
slope of the line, determined by linear regression with Sigma-
plot software.
Cell culture and co-transfection experiments
Human embryonic kidney HEK293 cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) High Glucose
(4.5 g/L, Biowest) supplemented with 10% fetal bovine serum
(FBS, Biowest, previously inactivated at 56C for 1 h), and sta-
bilized 1% penicillin-streptomycin solution (Sigma). Cells were
cultured at 37C in a humidified 5% CO2-containing atmo-
sphere and seeded in 6-well plates, at a density of 6£105 cells/
well, one day before transfection. The co-transfection mix
included the indicated GBD-ROS1_CD expression plasmid
(250 ng/well), the firefly luciferase reporter plasmid (250 ng/
well) and the Renilla luciferase control plasmid (25 ng/well),
all three diluted in 500 ml Opti-MEM I Reduced Serum
Media (Invitrogen) and 5 ml Lipofectamine LTXTM Reagent
(Invitrogen). After incubating for 30 min at room tempera-
ture, the co-transfection mix was added drop by drop to cells,
previously changed to a fresh culture medium (1.5 ml/well).
Forty-eight hours after co-transfection, cells were trypsinized
and harvested by centrifugation at 1800 rpm for 5 min for fur-
ther analysis.
Luciferase activity assay
Luciferase activity assay was performed using the Dual-
Luciferase Reporter Assay System (Promega). Cells were
washed once with PBS and lysed with 1X Passive Lysis Buffer
(1X PLB). After incubating for 15 min at 25C and gently shak-
ing, lysate samples were clarified by centrifuging for 30 sec at
17000 g and clear lysates were transferred to new tubes. Lucifer-
ase Assay Reagent II (LAR II) (50 ml/well) was added to
Greiner Bio-One mClear White Plates, and mixed with 20 ml of
clear lysate to determine firefly luciferase activity. The firefly
luciferase reaction was stopped and the Renilla luciferase reac-
tion was simultaneously initiated by adding 50 ml of Stop &
Glo Reagent. Measurements were carried out in a TECAN
infinite F200 PRO microplate reader and using the i-Control
1.7 software. Renilla luciferase activity was used to normalize
transfection yield and cell number in all co-transfection
experiments.
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Detection of protein expression by western blot analysis
Transient expression of GBD fusion proteins in HEK293 cells
after co-transfection was monitored by western-blot using an
anti-Flag antibody (Sigma). Briefly, cells were lysed in 1X RIPA
buffer (Sigma), containing 1% protease inhibitor cocktail set
III, EDTA-free (Calbiochem), and protein concentration was
determined by the Bradford assay.34 Total cell lysates (80 mg)
were subjected to SDS-PAGE (7% acrylamide/bisacrylamide,
37.5:1), and transferred to nitrocellulose membranes at 30 V at
4C overnight. After blotting, the membranes were blocked
with blocking solution [3% skim milk in TBS (10 mM Tris-HCl
pH 8 and 150 mM NaCl)] for 1 h at room temperature and
washed three times with TBS. Then, membranes were incu-
bated with Monoclonal Anti-Flag M2, Clone M2 (F1804)
antibody (Sigma) at a 1:1000 dilution in blocking solution at
4C overnight, washed three times with TBS supplemented
with 0.5% Tween-20 (TBS-T), and incubated with horseradish
peroxidase-conjugated anti-mouse (Cell Signaling) at a 1:3000
dilution in blocking solution for 1 h at room temperature.
Finally, after three washes with TBS-T, membranes were incu-
bated with ECL Prime Western Blotting Detection Reagent
(GE Healthcare) and images were captured using the LAS-3000
analyzer (Fujifilm). To verify equal loading of total cell lysates,
the Monoclonal Anti-Actin Antibody Clone AC-40 (Sigma)
was used at 1:2000 dilution in blocking solution at 4C over-
night, following the protocol described above.
Detection of co-transfection efficiency by flow cytometry
Co-transfection efficiency of HEK293 cells was monitored by
green fluorescent protein (GFP) signal count by flow cytome-
try. Cells were co-transfected with Renilla luciferase reporter
plasmid (25 ng/well), GBD-ROS1_CD or GBD-ROS1_CDmut
expressing constructs (250 ng/well), the methylated reporter
plasmid 5xUAS-TK-Luc (250 ng/well) and pACGFP-C1 plas-
mid (250 ng/well, Clontech), as described above. Cells were
harvested 48 h after co-transfection, washed once with PBS and
resuspended in PBS. GFP expression was analyzed using a BD
FACSCalibur flow cytometer (Becton Dickinson Biosciences)
and CellQuest software. Data were analyzed with FlowJo
software.
Analysis of firefly luciferase reporter gene expression by
quantitative Real-Time PCR
Total RNA was extracted from HEK293 cells 48 h after co-
transfection using the RNeasy Mini Kit 74016 (Qiagen). 1 mg
RNA was treated with 1 U DNase I, RNase-free (Thermo Scien-
tific), and subsequently used for cDNA synthesis using the
qSCRIPTTM cDNA synthesis Kit (Quanta Biosciences), follow-
ing the manufacturer’s instructions. Then, 1 ml cDNA synthesis
reaction was used as template in a 10 ml PCR reaction with spe-
cific primers (Table S3) and iQ SYBR Green Supermix (Bio-
Rad). All reactions were carried out on the CFX Connect Real-
Time System (Bio-Rad) and data were analyzed using the CFX
Manager Software (Bio-Rad). Expression levels relative to
GAPDH were determined using the 2¡DDCt method.35
DNA methylation analysis
The firefly luciferase reporter plasmid was re-isolated 48 h after
transfection by resuspending cells in 500 ml Cytoplasmic
Extraction Buffer [CPEB pH 7.9: 10 mM HEPES, 10 mM KCl,
1.5 mMMgCl2, 1 mM DTT, 0.5 mM PMSF, 1% protease inhib-
itor cocktail (535140, Calbiochem), 1% phosphatase inhibitor
cocktails 2 and 3 (p5726 and p0044, Sigma), 0.075% igepal CA-
630 (Sigma)]. After incubating 30 min on ice and centrifuging
10 min 1800 rpm at 4C, pellet was resuspended in 250 ml
CPEB without igepal. After incubating 10 min on ice and
centrifuging 10 min 1800 rpm at 4C, the pellet was resus-
pended in 500 ml Nuclear Extraction Buffer (NEB: 10 mM
HEPES pH 7.9, 420 mM NaCl, 1.2 mM MgCl2, 0.2 mM EDTA,
25% glycerol). The suspension was incubated for 30 min on ice
with repeated vortexing, and then centrifuged for 20 min at
13400 rpm and room temperature. The pellet was resuspended
in 250 ml NEB, and 250 ml Buffer 2 and 350 ml Buffer 3 of
NZYMiniprep (NZYTech Genes & Enzymes) kit. Henceforth,
NZYMiniprep (NZYTech Genes & Enzymes) manufacturer’s
protocol was followed, eluting plasmid DNA in 25 ml sterile
distilled water.
Re-isolated plasmid DNA (20 ml) was bisulfite-converted
using the EZ DNA Methylation-Gold Kit (Zymo Research) fol-
lowing the manufacturer’s instructions and eluted in 12 ml Elu-
tion Buffer. A 2-ml aliquot of bisulfite-treated plasmid DNA
was used for PCR amplification with Immolase DNA Polymer-
ase (Bioline) using specific primers (Table S4). DNA pyrose-
quencing was performed with 15 ml of PCR products and
specific sequencing primers (Table S4) on a PyroMark Q24
instrument (Qiagen), according to the manufacturer’s guide-
lines. Analysis of the percentage of methylation at each CpG
was determined using PyroMark Q24 Software (Qiagen).
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